Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging.

OBJECTIVE To retrospectively compare results from lymphatic mapping of pelvic sentinel lymph nodes (SLN) using fluorescence near-infrared (NIR) imaging of indocyanine green (ICG) and colorimetric imaging of isosulfan blue (ISB) dyes in women with endometrial cancer (EC) undergoing robotic-assisted lymphadenectomy (RAL). A secondary aim was to investigate the ability of SLN biopsies to increase the detection of metastatic disease. METHODS Thirty-five patients underwent RAL with hysterectomy. One mL ISB was injected submucosally in four quadrants of the cervix, followed by 0.5 mL ICG [1.25mg/mL] immediately prior to placement of a uterine manipulator. Retroperitoneal spaces were dissected for colorimetric detection of lymphatic pathways. The da Vinci(®) camera was switched to fluorescence imaging and results recorded. SLN were removed for permanent analysis with ultra-sectioning, H&E, and IHC staining. Hysterectomy with RAL was completed. RESULTS Twenty-seven (77%) and 34 (97%) of patients had bilateral pelvic or aortic SLN detected by colorimetric and fluorescence, respectively (p=0.03). Considering each hemi-pelvis separately, 15/70 (21.4%) had "weak" uptake of ISB in SLN confirmed positive with fluorescence imaging. Using both methods, bilateral detection was 100%. Ten (28.6%) patients had lymph node (LN) metastasis, and 9 of these had SLN metastasis (90% sensitivity, one false negative SLN biopsy). Seven of nine (78%) SLN metastases were ISB positive and 100% were ICG positive. Twenty-five had normal LN, all with negative SLN biopsies (100% specificity). Four (40%) with LN metastasis were detected only by IHC and ultra-sectioning of SLN. CONCLUSIONS Fluorescence imaging with ICG detected bilateral SLN and SLN metastasis more often than ISB, and the combination resulted in 100% bilateral detection of SLN. Ultra-sectioning/IHC of SLN increased the detection of lymph node metastasis.

[1]  Melissa P. Murray,et al.  Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. , 2011, Gynecologic oncology.

[2]  M. Ross,et al.  Recommendations for Sentinel Lymph Node Processing in Breast Cancer , 2002, The American journal of surgical pathology.

[3]  Kathleen R. Cho,et al.  Uterine Neoplasms. Clinical Practice Guidelines in Oncology. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  R. Rouzier,et al.  Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). , 2011, The Lancet. Oncology.

[5]  D. Cohn,et al.  Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. , 2012, Gynecologic oncology.

[6]  D. Cohn,et al.  Lymphadenectomy for endometrial cancer: the controversy. , 2010, Gynecologic oncology.

[7]  A. V. D. Van Der Zee,et al.  Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. , 2009, Gynecologic oncology.

[8]  J. Frangioni,et al.  Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation , 2010, Molecular imaging.

[9]  A. Giuliano,et al.  Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania , 2002, Cancer.

[10]  Andrea Mariani,et al.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. , 2008, Gynecologic oncology.

[11]  B. Têtu,et al.  Value of sentinel node mapping in cancer of the cervix. , 2011, Gynecologic oncology.

[12]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[13]  B. Fisher,et al.  National Surgical Adjuvant Breast and Bowel Project , 2020, Definitions.

[14]  Hein Putter,et al.  Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients , 2011, Breast Cancer Research and Treatment.

[15]  D. Metzinger,et al.  Nodal Metastasis Risk in Endometrioid Endometrial Cancer , 2012, Obstetrics and gynecology.

[16]  Carol L. Brown,et al.  Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? , 2009, Gynecologic oncology.

[17]  Anastasia Ivanova,et al.  Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study. , 2012, Gynecologic oncology.

[18]  T. Herzog,et al.  ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? , 2010, Gynecologic oncology.

[19]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Kusano,et al.  Sentinel Node Mapping Guided by Indocyanine Green Fluorescence Imaging: A New Method for Sentinel Node Navigation Surgery in Gastrointestinal Cancer , 2008, Digestive Surgery.

[21]  D. Taggart,et al.  Does off-pump total arterial grafting increase the incidence of intraoperative graft failure? , 2004, The Journal of thoracic and cardiovascular surgery.

[22]  Hani Rashid,et al.  Near infrared fluorescence imaging with robotic assisted laparoscopic partial nephrectomy: initial clinical experience for renal cortical tumors. , 2011, The Journal of urology.

[23]  V. Torri,et al.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.

[24]  T. Julian,et al.  Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. , 2007, The Lancet. Oncology.

[25]  R. Holloway,et al.  Robotic‐assisted surgery in the management of endometrial cancer , 2012, The journal of obstetrics and gynaecology research.

[26]  B. Karlan,et al.  Lymphadenectomy's role in early endometrial cancer: prognostic or therapeutic? , 2008, Journal of the National Cancer Institute.

[27]  R. Speich,et al.  Anaphylactoid reactions after indocyanine-green administration. , 1988, Annals of internal medicine.

[28]  J. Chan,et al.  Therapeutic role of lymph node resection in endometrioid corpus cancer , 2006, Cancer.

[29]  J. Herod,et al.  Efficacy of Systematic Pelvic Lymphadenectomy in Endometrial Cancer (MRC ASTEC Trial): A Randomized Study , 2009, International Journal of Gynecologic Cancer.

[30]  Yosuke Seki,et al.  Feasibility of a Lateral Region Sentinel Node Biopsy of Lower Rectal Cancer Guided by Indocyanine Green Using a Near-Infrared Camera System , 2010, Annals of surgical oncology.

[31]  Achim Schneider,et al.  Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  R. Barakat,et al.  Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer. , 2011, Gynecologic oncology.

[33]  P. Taylor,et al.  Surgical staging endometrial cancer. , 1996, Clinical obstetrics and gynecology.